⌘K

Home/Filings/4/0001209191-18-031475

4//SEC Filing

Bonner Michael 4

Accession 0001209191-18-031475

CIK 0001087294other

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 5:11 PM ET

Size

4.4 KB

Accession

0001209191-18-031475

Insider Transaction Report

Form 4

Period: 2018-05-17

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Purchase
Common Stock
2018-05-17$6.12/sh+400$2,448→ 18,054 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001666790

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 5:11 PM ET
Size: 4.4 KB

View on SEC.gov